The Living Guidelines: UA/NSTEMI Recomendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Polling Results for CLASS IIb Guidelines


 * CLASS IIb

For UA/NSTEMI patients in whom PCI is selected as a postangiography management strategy, it may be reasonable to omit an intravenous GP IIb/IIIa inhibitor if not started before diagnostic angiography for troponin-negative patients without other clinical or angiographic highrisk features. (Level of Evidence: C)

 Additional Management Considerations for Antiplatelet and Anticoagulant Therapy CLASS IIb Recommendation should be: CLASS I CLASS IIa CLASS IIb CLASS III